Français
ItalianoBond Pfizer 4.2% ( US717081FD01 ) in USD
| Issuer | Pfizer | ||||||
| Market price |  100.72 % ▼ |
||||||
| Country |  United States
|
||||||
| ISIN code |
 US717081FD01 ( in USD )
|
||||||
| Interest rate | 4.2% per year ( payment 2 times a year) | ||||||
| Maturity | 15/11/2030 | ||||||
|
Prospectus brochure in PDF format |
|||||||
| Minimal amount | / | ||||||
| Total amount | / | ||||||
| Cusip | 717081FD0 | ||||||
| Standard & Poor's ( S&P ) rating | A ( Upper medium grade - Investment-grade ) | ||||||
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) | ||||||
| Next Coupon | 15/11/2026 ( In 83 days ) | ||||||
| Detailed description |
Pfizer is a multinational pharmaceutical and biotechnology company headquartered in New York City that researches, develops, manufactures, and markets drugs and vaccines globally. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FD01, pays a coupon of 4.2% per year. The coupons are paid 2 times per year and the Bond maturity is 15/11/2030 The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FD01, was rated A2 ( Upper medium grade - Investment-grade ) by Moody's credit rating agency. The Bond issued by Pfizer ( United States ) , in USD, with the ISIN code US717081FD01, was rated A ( Upper medium grade - Investment-grade ) by Standard & Poor's ( S&P ) credit rating agency. |
||||||
| |||||||